Showing results (181-190 of 314) with videos related to

Sort By:
Pageof 32
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1989
Adductor laryngeal dystonia (spastic dysphonia): treatment with local injections of botulinum toxin (Botox)M F Brin, A Blitzer, S Fahn, et al.
Neurology|January 1, 1990
Dopa-responsive dystonia: the spectrum of clinical manifestations in a large North American familyT G Nygaard, J M Trugman, J G de Yebenes, et al.
Neurology|November 1, 1984
Genetic linkage analysis in primary torsion dystoniaS B Bressman, S Fahn, C Falk, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|August 25, 2010
Toxicity of the specific antimuscarinic agent methoctramine and other non-specific anticholinergic drugs in human neuroblastoma cell lines in vitroN Giladi, M Sutton, B Lo, et al.
Neurology|June 17, 1999
Falling asleep at the wheel: motor vehicle mishaps in persons taking pramipexole and ropiniroleS Frucht, J D Rogers, P E Greene, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1986
Analysis of the clinical course of non-Jewish, autosomal dominant torsion dystoniaR E Burke, M F Brin, S Fahn, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1989
Tardive akathisia: an analysis of clinical features and response to open therapeutic trialsR E Burke, U J Kang, J Jankovic, et al.
AJR. American Journal of Roentgenology|August 1, 1987
Study of movement disorders and brain iron by MRJ N Rutledge, S K Hilal, A J Silver, et al.
The Annals of Otology, Rhinology, and Laryngology|November 1, 1985
Electromyographic findings in focal laryngeal dystonia (spastic dysphonia)A Blitzer, R E Lovelace, M F Brin, et al.
Clinical Neuropharmacology|December 1, 1982
Inhibition by lithium of PGE1-sensitive adenylate cyclase in neuroblastoma X glioma hybrid cells: approach to the attenuation of the opiate withdrawal syndromeA Reches, D Benalal, B A Weissman, et al.
Pageof 32